Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Da-Qiang Li

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2025
Secernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast CancerMin-Ying Huang, Jia-Yang Cai, Shao-Ying Yang, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancerJin-Li Wei, Si-Yu Wu, Yun-Song Yang, et al.
Cancer Research|May 15, 2024
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast CancerMin-Ying Huang, Shu-Yuan Hu, Jia Dong, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasisDa-Qiang Li, Yi-Feng Hou, Jiong Wu, et al.
Clinical and Translational Medicine|December 30, 2020
Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progressionYing-Ying Liu, Sa Zhang, Tian-Jian Yu, et al.
Breast Cancer Research : BCR|July 4, 2018
Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancerXin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, et al.
Breast Cancer Research and Treatment|October 12, 2007
Identification of the functional role of AF1Q in the progression of breast cancerXin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, et al.
Cell Metabolism|October 18, 2022
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategyFan Yang, Yi Xiao, Jia-Han Ding, et al.
The Journal of Biological Chemistry|September 10, 2013
Mechanism of MTA1 protein overexpression-linked invasion. MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and functionDeivendran Sankaran, Suresh B Pakala, Vasudha S Nair, et al.
Cancer Letters|June 7, 2024
Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2ALisa Andriani, Yun-Xiao Ling, Shao-Ying Yang, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2025
Secernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast CancerMin-Ying Huang, Jia-Yang Cai, Shao-Ying Yang, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancerJin-Li Wei, Si-Yu Wu, Yun-Song Yang, et al.
Cancer Research|May 15, 2024
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast CancerMin-Ying Huang, Shu-Yuan Hu, Jia Dong, et al.
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasisDa-Qiang Li, Yi-Feng Hou, Jiong Wu, et al.
Clinical and Translational Medicine|December 30, 2020
Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progressionYing-Ying Liu, Sa Zhang, Tian-Jian Yu, et al.
Breast Cancer Research : BCR|July 4, 2018
Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancerXin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, et al.
Breast Cancer Research and Treatment|October 12, 2007
Identification of the functional role of AF1Q in the progression of breast cancerXin-Zhong Chang, Da-Qiang Li, Yi-Feng Hou, et al.
Cell Metabolism|October 18, 2022
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategyFan Yang, Yi Xiao, Jia-Han Ding, et al.
The Journal of Biological Chemistry|September 10, 2013
Mechanism of MTA1 protein overexpression-linked invasion. MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and functionDeivendran Sankaran, Suresh B Pakala, Vasudha S Nair, et al.
Cancer Letters|June 7, 2024
Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2ALisa Andriani, Yun-Xiao Ling, Shao-Ying Yang, et al.
Pageof 11